Although PSCA is recognized as a membrane glycoprotein primarily associated with the prostate [24,40], its upregulation has also been noted in a range of malignancies, including urinary bladder cancer, renal cell carcinoma, ovarian mucinous tumor, and PDAC [41,42,43,44]. This evidence concerns the gene PSCA and hereditary clear cell renal cell carcinoma.